Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Bladder Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03591367
What this trial is testing

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Who this might be right for
Bladder CancerBladder DiseaseBladder Neoplasm+1 more
Mansoura University 115
Testing effectiveness (Phase 2)Study completedNCT00722553
What this trial is testing

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Who this might be right for
Carcinoma, Transitional CellBladder CancerBladder Neoplasm
Acrotech Biopharma Inc. 30
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT03636256
What this trial is testing

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more
NanOlogy, LLC 36
Early research (Phase 1)Active Not RecruitingNCT04459273
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Who this might be right for
Bladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more
Jonsson Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT04902040
What this trial is testing

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Who this might be right for
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
M.D. Anderson Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT04534075
What this trial is testing

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of RectumMalignant Neoplasm of Anus+7 more
Sahlgrenska University Hospital 354
Not applicableLooking for participantsNCT07165236
What this trial is testing

Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor

Who this might be right for
Cognitive DeclineUrinary Bladder CancerFrail+8 more
Osijek University Hospital 42
Large-scale testing (Phase 3)Ended earlyNCT01200992
What this trial is testing

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder NeoplasmNeoplasm Recurrence, LocalTransitional Cell, Carcinoma+2 more
Bioniche Life Sciences Inc. 84
Not applicableEnrolling By InvitationNCT06940648
What this trial is testing

Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial

Who this might be right for
Bladder Neoplasm
Virtuoso Surgical, Inc. 30
Not applicableLooking for participantsNCT07234968
What this trial is testing

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Study completedNCT04576286
What this trial is testing

Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder

Who this might be right for
Urinary Bladder Neoplasm
Ain Shams University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Not applicableEnded earlyNCT05819827
What this trial is testing

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Who this might be right for
Bladder CancerProstate CancerTesticular Cancer+6 more
Mayo Clinic 13
Very early researchStudy completedNCT03204266
What this trial is testing

Oral Supplementation to Enhance Recovery Pilot Study

Who this might be right for
Malignant Neoplasms of Urinary Tract
M.D. Anderson Cancer Center 46
Post-approval studies (Phase 4)Study completedNCT03138967
What this trial is testing

Investigation of Sugammadex in Outpatient Urological Procedures

Who this might be right for
Malignant Neoplasms of Urinary TractBladder Cancer
M.D. Anderson Cancer Center 54
Next Page